潮州白癜风怎么治最好(汕头哪里能治疗好白癜风) (今日更新中)

Online interaction with one another has gotten to the point where websites and apps are having to remind us how to act. The neighborhood app Nextdoor has gotten a reputation for sometimes strange posts that can prompt mean and off-color responses.There's a whole Twitter account dedicated to examples. Now, Nextdoor has rolled out a new feature to try and keep some civility online. It's called a "Kindness Reminder." If you try and post a response that's similar to one that's been flagged in the past, you'll get a reminder of the community guidelines and that they can change your response. But you can still post what you want. “One of the problems of the age we're living in is that people don't necessarily share a common understanding of what counts as civil interaction,” said Keith Bybee, a professor of law and political science at Syracuse University.Bybee says some people are strategically not civil or just plain rude in order to attract attention. You see it in politics and trolling behavior. But in the end, civility benefits everyone. “Civility is sort of the lubricant that makes social interaction possible,” Bybee said. “It allows us to live in a diverse, heterogeneous society but nonetheless coordinate our actions for common purposes, so it’s important to find a way to get along with strangers.”Ultimately, you have to care what the other person thinks of you to achieve civility. 1418

Not everyone is loving it. An iconic Times Square McDonald's, opened in 1984, shut its doors early Wednesday morning, a company spokesperson said. The 42nd Street location closed at 4 a.m. “McDonald’s reviews its restaurant portfolio on a regular basis to make the best decisions for our business moving forward," the spokesperson said. "The closing of the 42nd Times Square restaurant, which was planned before the pandemic, was a difficult decision, and allows us to focus on serving customers a few blocks away at the new flagship McDonald’s on 45th and Broadway and in the neighboring communities.”When it opened, McDonald's CEO Chris Kempczinski said the 45th Street location was about "showing off what McDonald’s can do." This article was written by Aliza Chasan for WPIX. 803

The second presidential debate scheduled for October 15 will no longer take place at the University of Michigan.It will instead be held at the Adrienne Arsht Center for the Performing Arts of Miami-Dade County in Miami, Florida.The University of Michigan concluded that it is not feasible to host the debate as planned, the Commission on Presidential Debates said.View the full schedule for presidential debates below: First presidential debate:Tuesday, September 29, 2020University of Notre Dame, Notre Dame, INVice presidential debate:Wednesday, October 7, 2020The University of Utah, Salt Lake City, UTSecond presidential debate:Thursday, October 15, 2020Adrienne Arsht Center for the Performing Arts, Miami, FLThird presidential debate:Thursday, October 22, 2020Belmont University, Nashville, TN WXYZ was first to report this story. 859

At the Denver Public Library, story time is one of the most popular programs. They're interacting with me, they're responding to questions, they're rhyming,” says children’s librarian Warren Shanks. But in the age of social media, a principal in Texas is offering children a more modern option: a digital version of story time. Principal Dr. Belinda George hosts the story hour called "Tucked in Tuesday" on Facebook Live. “You can't just stay stagnant. You'll lose the kids,” Dr. George says. “You got to meet them where they are.” The principal says she got the idea before Christmas break. “I knew I would miss my scholars,” she says. So, she decided to read them a story, while in her pajamas, from her living room. She decided to keep reading, with the goal of bridging the gap between home and school.What started with 35 students from her Texas elementary school, has grown to hundreds of kids and parents around the world. The response has been overwhelming. “In my head, I'm doing something that I love and I’m doing something for kids, and so the attention that I’m getting is kind of like I don't know the big deal yet,” Dr. George says. Now, authors are sending in books for her to read, and some are even joining her during story time. But Dr. George says what's most important is that her students are learning.“They're learning to read with expression,” she says. “They're learning that the principal cares.” 1438

INDIANAPOLIS — The U.S. Food and Drug Administration on Monday granted emergency use authorization to Eli Lilly and Company's experimental COVID-19 antibody treatment bamlanivimab.According to a statement from the company, the drug is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test who are at high risk for progressing to severe COVID-19 and/or hospitalization. Lilly said in a statement the drug should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion."This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients — adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic," David A. Ricks, Lilly's chairman and CEO, said. "The rapid development and availability of bamlanivimab could not have been achieved without the relentless work of our Lilly team, collaboration across the industry and the urgent work being done by the government to ensure appropriate allocation to patients who need it the most."The emergency use authorization is based on data from BLAZE-1, a randomized, double-blind, placebo-controlled Phase 2 study in patients with recently diagnosed mild to moderate COVID-19 in the outpatient setting. Patients treated with the drug showed reduced viral load and rates of symptoms and hospitalization, Lilly said in the statement. Infusion reactions and other allergic hypersensitivity events have been reported, Lilly said. The emergency use authorization includes a warning for hypersensitivity including anaphylaxis and infusion-related reactions.Lilly said the drug is not authorized for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy due to COVID-19 or who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity."The BLAZE-1 data show bamlanivimab, when given early in the disease course, may help patients clear the virus and reduce COVID-related hospitalizations, supporting our belief that neutralizing antibodies can be an important therapeutic option for patients fighting this virus," Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories, said. "We're proud of the speed with which we have been able to bring patients this therapy specifically designed to treat COVID-19. We thank those who have contributed to this medical advancement, particularly the clinical trial investigators and participants around the country." This article was written by Bob Blake for WRTV. 2906

来源：资阳报